Walgreens finalizes BioScrip deal
Deerfield, Ill. -- Walgreens on Monday announced it has completed its acquisition of certain assets of BioScrip’s community specialty pharmacies and centralized specialty and mail-service pharmacy businesses. The transaction represents a total deal value of approximately $225 million.
“We welcome the BioScrip leaders and employees involved in the transaction to the Walgreens family,” stated Kermit Crawford, Walgreens president pharmacy, health and wellness. “BioScrip’s clinically focused community specialty pharmacies and access to additional limited distribution drug therapies, combined with Walgreens' existing nationwide network of retail and health system pharmacies, creates a strong network of support for our core drug store business to provide specialty pharmacy solutions to our patients. This acquisition also significantly expands our nationwide reach to an additional half-million patients with chronic and complex health conditions.”
Beyond growing Walgreens' specialty pharmacy footprint, the acquisition also will help grow Walgreens' centralized specialty and mail-service pharmacy operations, the company stated.
The acquired community specialty pharmacy business includes a national network with 30 locations in 16 states across the United States and the District of Columbia, primarily serving HIV, oncology and transplant patients. Walgreens also acquired certain assets of BioScrip's centralized specialty pharmacy business and traditional mail-service pharmacy business that dispenses prescriptions for, among others, Drugstore.com, which was acquired by Walgreens in June 2011.